Blood PhenoAge vs Epigenetic Clock Tests

If you’ve decided to measure your biological age, you’ll quickly hit a fork in the road: a blood-based test like PhenoAge, or an epigenetic clock that reads your DNA. They sound like competitors for the same job, and marketing often presents them that way. But they’re built from different data, cost different amounts, and measure subtly different things. This is a commercial-investigation guide to help you decide which one your money and attention should go to first, starting from the fact that the PhenoAge biological age calculator can give you a validated estimate from lab work you may already have.

This is educational, not medical advice. No biological-age test diagnoses disease or should drive medical decisions on its own.

Two different ways to estimate the same thing

Both approaches try to answer “how old is your body, really?”, but from opposite ends of biology.

Blood PhenoAge works from downstream physiology. In the 2018 work by Levine and colleagues, researchers screened 42 clinical markers against 23 years of mortality data in NHANES III and distilled them to nine biomarkers plus chronological age: albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean cell volume, red cell distribution width, alkaline phosphatase, and white blood cell count. Those nine numbers are combined into a “phenotypic age” in years. It’s a readout of how your organs and immune system are functioning right now.

Blood PhenoAge is built from nine routine lab markers plus age: cheap and validated against mortality.

Epigenetic clocks work from upstream molecular marks. They measure DNA methylation (chemical tags on your DNA that shift with age) at specific sites called CpGs. Horvath’s original 2013 clock (published in Genome Biology) used 353 CpG sites across 51 tissue types and predicted chronological age with a median error of a few years. The same 2018 Levine paper also built DNAm PhenoAge, an epigenetic clock trained on 513 CpGs to predict the blood-based PhenoAge, and it outperformed the earlier Horvath and Hannum clocks at predicting 10- and 20-year mortality. Newer entries like GrimAge and DunedinPACE push further: DunedinPACE uses 173 carefully selected CpGs to estimate your pace of aging, where a value of 1.0 means one biological year per calendar year. For the full mechanics, see our explainer on how epigenetic clocks measure biological age.

Head to head

	Blood PhenoAge	Epigenetic clocks
What it reads	9 routine lab markers + age	DNA methylation at 100s of CpG sites
Sample	Standard blood draw	Blood or saliva, specialized assay
Typical cost	Low, often from labs you already have	Higher; a dedicated commercial test
What it captures	Current organ & immune function	Molecular aging signature
Evidence base	Strong mortality validation (NHANES)	Strong (esp. DunedinPACE, GrimAge)
Reliability	High, standardized clinical assays	Varies; newer clocks built for reliability
Actionable follow-up	Yes; each marker points somewhere	Less direct; a composite score

Cost and access: the real deciding factor for most people

This is where the choice usually gets made. Blood PhenoAge runs on a comprehensive metabolic panel and a complete blood count, tests that are inexpensive, widely available, and often already in your medical record from a routine physical. You can frequently compute a PhenoAge with zero additional testing.

Epigenetic clock tests are a separate purchase, usually costing far more, and the market is a patchwork of providers using different algorithms. Two companies can hand you two different “epigenetic ages” from the same spit sample because they’re running different clocks. That’s not fraud (it reflects an unsettled field), but it means you’re paying a premium for a number that’s harder to interpret and compare.

Reliability: an underrated issue

A biological-age test is only useful if it gives you a similar answer when nothing has changed. Blood PhenoAge inherits the reliability of standard clinical chemistry, which is tightly controlled.

Early epigenetic clocks had a quieter weakness: test-retest reliability. Run the same sample twice and first-generation clocks could return meaningfully different ages, because many individual CpG measurements are noisy. The field has responded: DunedinPACE was deliberately built only from CpGs with acceptable reliability and reports excellent test-retest agreement (ICC around 0.96 across replicate 450k arrays). But it’s a reason to be skeptical of any clock that doesn’t publish its reliability, and to weight a single epigenetic reading cautiously.

Which predicts outcomes better?

Both predict mortality and disease, and the honest answer is that the best modern epigenetic clocks are excellent. DunedinPACE, for instance, was associated with higher mortality in the Framingham Offspring cohort (hazard ratio 1.65, 95% CI 1.51–1.79) and with incident chronic disease and disability. DNAm PhenoAge similarly beat older clocks on mortality prediction.

But “better in a research cohort” doesn’t automatically mean “better value for you.” Blood PhenoAge was itself derived directly from mortality data and carries strong validation, and it comes with a bonus the clocks don’t: each of its nine inputs is independently interpretable. A high glucose, a low albumin, an elevated CRP: each points at something you can investigate and potentially act on. An epigenetic clock hands you a single composite number with far less to grab onto. To decide which individual markers are worth tracking regardless of which test you pick, see which biomarkers of aging are worth tracking.

A sensible way to choose

• Start with blood PhenoAge. It’s cheap or free, well-validated, standardized, and actionable. For most people it’s the highest-value first move, full stop.
• Consider an epigenetic clock as a supplement, not a replacement, especially if you’re tracking an intervention over time and want a second, upstream perspective. Pick a provider that publishes its clock (ideally DunedinPACE or GrimAge) and its reliability.
• Don’t expect the two to agree. They measure related but distinct things. A gap between them is information, not an error.
• Retest thoughtfully. Biological age moves slowly. Annual retesting is plenty; chasing month-to-month wiggles mostly measures noise.

The takeaway

Blood PhenoAge and epigenetic clocks aren’t rivals; they’re two lenses on aging, one physiological and cheap, the other molecular and pricier. For nearly everyone, the smart sequence is to establish a baseline with the blood-based approach first, because it costs little, rests on strong mortality evidence, and tells you where to look next. Reserve the epigenetic test for when you want a complementary upstream reading and have chosen a provider transparent about its methods. Get your starting number with the PhenoAge biological age calculator, then decide whether a DNA-based test adds anything for you.

Sources

• Levine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018 (PMC5940111)
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013 (PMID 24138928)
• Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022 (PMC8853656)
• GrimAge (Lu et al., 2019) and the Hannum clock (Hannum et al., 2013) are referenced in general terms and are not linked here.